Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | ||
Ligand | BDBM350893 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Inhibition Assay | ||
IC50 | 4560±n/a nM | ||
Citation | Martinez Gil, A; Gil Ayuso-Gontan, CB; Perez Fernandez, DI; Garcia Fernandez, AM S-substituted quinazolines and their therapeutic applications for the treatment of diseases mediated by PDE7 US Patent US9796687 Publication Date 10/24/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | |||
Name: | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | ||
Synonyms: | 3',5'-cyclic phosphodiesterase | PDE7A | PDE7A_HUMAN | Phosphodiesterase 7 | Phosphodiesterase 7 (PDE7) | Phosphodiesterase 7A | Phosphodiesterase 7A (PDE7A1) | ||
Type: | Enzyme | ||
Mol. Mass.: | 55514.96 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q13946 | ||
Residue: | 482 | ||
Sequence: |
| ||
BDBM350893 | |||
n/a | |||
Name | BDBM350893 | ||
Synonyms: | 2-Cyclopropylmethylthio-3-(2,6-difluorophenyl)-8-methyl-4-oxo-3,4-dihydroquinazoline | US9796687, Compound 15 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H16F2N2OS | ||
Mol. Mass. | 358.405 | ||
SMILES | Cc1cccc2c1nc(SCC1CC1)n(-c1c(F)cccc1F)c2=O |(5.33,1.54,;5.33,,;6.67,-.77,;6.67,-2.31,;5.33,-3.08,;4,-2.31,;4,-.77,;2.67,,;1.33,-.77,;;,1.54,;1.33,2.31,;2.1,3.64,;2.87,2.31,;1.33,-2.31,;,-3.08,;-1.33,-2.31,;-1.33,-.77,;-2.67,-3.08,;-2.67,-4.62,;-1.33,-5.39,;,-4.62,;1.33,-5.39,;2.67,-3.08,;2.67,-4.62,)| | ||
Structure |